Broadly neutralising antibodies (bnAbs) are one of the most active and exciting areas in HIV research. Last year Spotlight reported on a “proof of concept” study showing that a specific bnAb can successfully prevent infection with certain strains of HIV. Now, we also have intriguing findings suggesting that bnAbs may have a role to play in the treatment of HIV in children. Elri Voigt reports.
HIV and ageing were one of the hot topics at the recently held Conference on Retroviruses and Opportunistic Infections. Elri Voigt reports.
Even though the rate of new HIV infections in young women and adolescent girls remains stubbornly high, provision and uptake of pills that can prevent HIV infection have generally been slow and lagging. One potential solution presented at the recent Conference on Retroviruses and Opportunistic Infections is to provide the pills at schools. Tiyese Jeranji reports.
A new study has analysed the change in the rate of new HIV infections from 2010 to 2019 and found that HIV incidence in South Africa has halved since 2010. This is mainly due to antiretroviral treatment and condom promotion, but male medical circumcision and behaviour change after HIV diagnosis had a role too, writes Leigh Johnson.
People who belong to key populations, such as men who have sex with men, often report that it is difficult for them to access health services – for example, due to negative healthcare worker attitudes. Now, a large survey published last week by community healthcare monitoring group Ritshidze provides important statistics that not only confirm that such experiences are widespread but also help in pinning down some specific issues. Tiyese Jeranji reports.
COVID-19 will continue to dominate headlines in 2022, but from National Health Insurance to the availability of a new HIV prevention injection, it will also be an important year for other areas of health service delivery and for health system governance and reforms. Here is Spotlight’s pick of the top ten issues to keep an eye on.
It wasn’t rocket science when we predicted at the start of 2021 that South Africa’s biggest challenge this year would be to get COVID-19 shots into as many arms as possible. But the way it has played out with multiple setbacks and scrambling problem-solving is not something anyone could have predicted. In fewer than a thousand words, Spotlight editor Marcus Low takes a look back at a tumultuous year in health in South Africa.
We reflect in pictures South Africa’s journey in the struggle against HIV since 2000.
“Driving a fast car”; “getting the top three letters”; or “playing the lotto” – nearly 40 years from when HIV was first described, the virus is still a thing of euphemism and stigma. It’s also still infecting at least 4 000 people a day around the world, most of them young people, especially girls and young women. Ufrieda Ho reports.
On World AIDS Day, Dr Thembisile Xulu, CEO of the South African AIDS Council will share a podium with Deputy President David Mabuza for the country’s official commemoration event in Limpopo. Bienne Huisman spoke to her about how she settled into the CEO role and what keeps her busy.
One of the biggest breakthroughs in HIV treatment in the 1990s came when three different antiretrovirals were used together, suppressing viral replication in multiple ways and preventing the development of drug resistance. Now, trials are showing that certain combinations of just two antiretrovirals might be as good as three, potentially bringing an end to a quarter of a century of triple therapy dominance. Elri Voigt reports.
The top priority in our HIV programme should be to make it as easy as possible for people to start and stay on treatment. Yet, as a number of provincial reports released this year by community monitoring group Ritshidze have shown, there are many healthcare system factors that work directly against this objective. Spotlight editor Marcus Low considers some of the potential solutions.